Keywords:
selenium; hydrogel; biomaterial; antioxidant; oxidative stress; antibacterial; wound healing; chronic wound A wound is a defect or break in the skin caused by physical or thermal damage. Depending on the area of skin affected, there may be a series of alterations in the organism, such as blood loss, dehydration, difficulty in maintaining body temperature, or infection. The wound-healing process represents a complex series of biological events to restore the skin barrier function. Numerous studies have shown that low levels of reactive oxygen species (ROS) promote normal wound healing by stimulating cell migration and angiogenesis, but excessive ROS can occur in chronic wounds. In chronic wounds, a sustained inflammatory response leads to a large accumulation of ROS, which exceeds the physiological antioxidant capacity, impeding cell migration and proliferation and thus preventing tissue remodeling. It has been shown that antioxidants can accelerate wound healing, especially for chronic wounds. In this study, we developed a hydrogel based on a natural polymer and modified it with selenium to add antioxidant and antimicrobial properties. The synthesis reaction was confirmed with nuclear magnetic resonance (NMR) and atomic absorption spectroscopy. The mechanical properties of the hydrogel were characterized by rheological tests. Viability assays were performed with human dermal fibroblasts. Hence, we developed an antioxidant and antimicrobial hydrogel with good biocompatible properties, which seems to be a promising therapy for the treatment of chronic wounds.
Author Contributions
Conceptualization, D.P. and M.M.M.; methodology, M.P.-A.; investigation, M.P.-A.; resources, T.J., C.S., F.P. and M.M.M.; writing—original draft preparation, M.P.-A.; writing—review and editing, D.P. and M.M.M.; supervision, T.J., D.P., F.P. and M.M.M.; project administration, C.S. and F.P.; funding acquisition, C.S., F.P. and M.M.M. All authors have read and agreed to the published version of the manuscript.
Funding
This work has been supported by the European Union’s H2020 research and innovationprogramme under grant agreement 874827 (BRAV∃); Instituto de Salud Carlos III co-financed by European Regional Development Fund-FEDER “A way to make Europe” PI19/01350; Ministerio de Ciencia e Innovación CARDIOPRINT (PLEC2021-008127); Gobierno de Navarra IMPRIMED (0011-1411-2021-000096) and BIOHEART (0011-1411-2022-000071) and Gobierno de Navarra BIOGEN (PC020-021-022), and Instituto de Salud Carlos III and “Financiado por la Unión Europea–NextGenerationEU. Plan de Recuperación Transformación y Resiliencia” RICORS TERAV (RD21/0017/0009) FEDER. M.P.-A. is supported by Gobierno de Navarra with a predoctoral fellowship (0011-0537-2020-000082).
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors on request.
Conflicts of Interest
The authors declare no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).